77 Views | 34 Downloads
Boris Reizis, boris.reizis@nyulangone.org
Jill P. Buyon, jill.buyon@nyulangone.org
J. Hartl, L. Serpas, A. Rashidfarrokhi, Y. Wang, O.A. Perez, B. Sally, V. Sisirak, C. Soni, and G.J. Silverman performed experiments and analyzed and interpreted results. A. Khodadadi-Jamayran, A. Tsirigos, and M.Y. Kim analyzed results. A.S. Chida and I. Sanz developed and provided reagents. I. Caiello, C. Bracaglia, S. Volpi, G.M. Ghiggeri, H.M. Belmont, R.M. Clancy, P.M. Izmirly, and J.P. Buyon obtained and provided patient samples. J.P. Buyon and B. Reizis conceived and supervised the project. J. Hartl, L. Serpas, and B. Reizis wrote the original manuscript. All authors reviewed and edited the manuscript.
P. Izmirly reported personal fees from GlaxoSmithKline outside the submitted work. J.P. Buyon reported personal fees from Bristol-Myers Squibb LN advisory board, personal fees from GSK panel on LN, personal fees from Amgen, and personal fees from Ventus outside the submitted work. B. Reizis reported being an advisor at Related Sciences. No other disclosures were reported.
This work was supported by National Institutes of Health grants AR071703 (B. Reizis and J.P. Buyon), AR070591 (B. Reizis, G.J. Silverman, J.P. Buyon, and R.M. Clancy), CA232666 (O.A. Perez), AI100853 (O.A. Perez, L. Serpas, and A. Rashidfarrokhi), AR069515 (L. Serpas), and GM136573 (L. Serpas). This work was also supported by the Lupus Research Alliance (B. Reizis), the Colton Center for Autoimmunity (B. Reizis and J.P. Buyon), and the German Research Foundation (J. Hartl).
© 2021 Hartl et al.